Table 1 Clinical characteristics according to aPWV groups

Clinical demographics

 Age

51.2 ± 14

63 ± 12

<0.001*

 Male gender (%)

45.4

41.2

0.455

 BSA (g/m2)

1.88 ± 0.21

1.87 ± 0.22

0.906

Cardiovascular risk factors

 BMI (g/m2)

26.9 ± 5

27.8 ± 5.1

0.367

 eGFR (mL/min/1.73 m²)

48.95 ± 20.1

30.5 ± 15.4

<0.001*

 Systolic BP (mmHg)

127.2 ± 20.4

140.5 ± 18.5

0.01*

 Diastolic BP (mmHg)

77.9 ± 10.6

79.5 ± 10.5

0.451

 Diabetes (%)

20.3

71

<0.001*

 Hypertension (%)

62.5

82.8

<0.001*

 Family history of IHD (%)

29.7

26.8

0.755

Smoking status (%) Current

 Current

6.3

9.8

0.295

 Ex

9.4

9.8

 Never

45.3

34.1

Medication

 Aspirin (%)

28

37

0.367

 Clopidogrel (%)

2

7

0.135

 ACE-I (%)

34

69

<0.001*

 ARBs (%)

53

51

0.858

 Beta-blockers (%)

16

22

0.416

 CCB dihydropyridine (%)

25

38

0.151

 Loop diuretic (%)

22

34

0.112

 Thiazide diuretic (%)

2

10

0.06

 Any antihypertensive (%)

40.1

87.2

 Statins (%)

61

80

0.110

 Prednisolone (%)

22

10

0.125

 Metformin (%)

9

18

0.081

 Gliclazide (%)

9

12

0.649

 Insulin (%)

8

41

<0.001*